This Kalorama Information report - The World Market for Clinical Nutrition Products - focuses on three primary segments of essential medical nutrition:
Coverage of Issues and Trends in Clinical Nutrition
There are several issues and trends that are impacting the clinical nutrition market, including:
Competition in the clinical nutrition market is dominated by a handful of companies, ranging from global nutritional manufacturers to leading pharmaceutical companies. The majority of competitive participation is in developed regions such as the United States, Western Europe, and Japan. However, many companies are expanding into less developed regions, intensifying competition in less tapped markets. China, for example, is among the expanding competitive regions as companies continue to break into the growing demand for clinical nutrition in new world markets. Companies highlighted in this study include:
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 80 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Specific interviews with nutrition company representatives included marketing directors, division managers, and product representatives.
All market data pertains to the world market at the manufacturers’ level. The base year for data was 2010. Historical data was provided for the years 2005 through 2009, with forecast data provided for 2011 through 2015. Compound annual growth rates (CAGRs) are provided for the 2005-2010, 2010-2015 and 2005-2015 periods for each industry segment covered. Competitive analysis is provided for the year 2010. The forecasted market analysis for 2010-2015 was based on demographic trends, new developments, and global expansion.
All Kalorama reports advertise the single user price. Use is limited to one user. We also feature department and global pricing for reports that we be utilized by more than one user at your company. Please consult ask your sales representative or select the correct license on our website.
For Kalorama's take on the healthcare news of the week, based on our analysis of healthcare markets, follow Kalorama Information's Key Point Blog at http://kaloramakeypoint.blogspot.com/
Increasing birth rates and aging populations in China and other developing nations are driving a 6.4% growth rate for the emerging markets segment of the $23 billion market for global clinical nutrition. Healthcare research publisher Kalorama Information found that sales of nutritional products for infants lead the market followed closely by enteral nutrition, according to its latest report, Clinical Nutrition Products, 4th Edition.
Growth in infant nutrition is due to a significant rise in birth rates, especially in emerging markets such as Pakistan with 25.3 births per 1,000 population, followed by India at 21.3 per 1000 population. The report finds additional growth in infant nutrition sales in China due to approximately 16 million births annually. Although Indonesia has a similar birth pattern to the United States, the infant formula market has been severely underserved, leaving room for growth in the range of 15-20% annually.
"Demand in the new high-birth rate markets will drive increasing sales of infant nutrition products for manufacturers in the future," notes Bruce Carlson, publisher of Kalorama Information. "Efforts by the WHO, which supports breastfeeding, will give manufacturers new opportunities in marketing follow-on or weaning formulas."
As new births drive the market for infant nutrition, the aging population is driving the market for enteral nutrition, often identified as tube feeding. While the average rate of growth for this population is 2.3%, emerging markets, including Brazil, India and Indonesia, are experiencing an increase of 4% annually. The report finds other factors driving growth include increased usage of enteral products in home care settings, as well as a focus towards providing nutrition on a disease-specific basis.
"The growth is not all attributed to the aging population," adds Carlson. "Malnutrition amongst the elderly in Brazil and poor knowledge of the benefits of enteral nutrition in China establish areas of opportunity beyond the growing market."
The report, Clinical Nutrition Products, 4th Edition, delivers an insight into the global market for infant, enteral and parenteral nutrition, focusing on the United States, Europe, Japan, China and other developing nations. The report includes a competitive analysis in each segment and profiles top companies in the industry.